{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:39:37Z","timestamp":1788914377570,"version":"build-2803163510"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T00:00:00Z","timestamp":1691712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T00:00:00Z","timestamp":1691712000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci. China Life Sci."],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s11427-023-2410-5","type":"journal-article","created":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T03:08:05Z","timestamp":1691982485000},"page":"2201-2213","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["A pan-coronavirus peptide inhibitor prevents SARS-CoV-2 infection in mice by intranasal delivery"],"prefix":"10.1007","volume":"66","author":[{"given":"Lili","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anqi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangming","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiantao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guizhen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaogui","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qihui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George Fu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,11]]},"reference":[{"key":"2410_CR1","doi-asserted-by":"publisher","first-page":"3519","DOI":"10.1038\/s41467-022-31200-y","volume":"13","author":"F Armando","year":"2022","unstructured":"Armando, F., Beythien, G., Kaiser, F.K., Allnoch, L., Heydemann, L., Rosiak, M., Becker, S., Gonzalez-Hernandez, M., Lamers, M.M., Haagmans, B.L., et al. (2022). SARS-CoV-2 Omicron variant causes mild pathology in the upper and lower respiratory tract of hamsters. Nat Commun 13, 3519.","journal-title":"Nat Commun"},{"key":"2410_CR2","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/s11427-021-1964-4","volume":"65","author":"C Bai","year":"2022","unstructured":"Bai, C., Zhong, Q., and Gao, G.F. (2022). Overview of SARS-CoV-2 genome-encoded proteins. Sci China Life Sci 65, 280\u2013294.","journal-title":"Sci China Life Sci"},{"key":"2410_CR3","first-page":"521","volume":"64","author":"Y Cao","year":"2023","unstructured":"Cao, Y., Jian, F., Wang, J., Yu, Y., Song, W., Yisimayi, A., Wang, J., An, R., Chen, X., Zhang, N., et al. (2023). Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution. Nature 64, 521\u2013529.","journal-title":"Nature"},{"key":"2410_CR4","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.cell.2020.06.035","volume":"182","author":"L Dai","year":"2020","unstructured":"Dai, L., Zheng, T., Xu, K., Han, Y., Xu, L., Huang, E., An, Y., Cheng, Y., Li, S., Liu, M., et al. (2020). A universal design of betacoronavirus vaccines against COVID-19, MERS, and SARS. Cell 182, 722\u2013733.e11.","journal-title":"Cell"},{"key":"2410_CR5","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1126\/science.abf4896","volume":"371","author":"RD de Vries","year":"2021","unstructured":"de Vries, R.D., Schmitz, K.S., Bovier, F.T., Predella, C., Khao, J., Noack, D., Haagmans, B.L., Herfst, S., Stearns, K.N., Drew-Bear, J., et al. (2021). Intranasal fusion inhibitory lipopeptide prevents direct-contact SARS-CoV-2 transmission in ferrets. Science 371, 1379\u20131382.","journal-title":"Science"},{"key":"2410_CR6","doi-asserted-by":"publisher","first-page":"6563","DOI":"10.1038\/s41467-021-26809-4","volume":"12","author":"D Delaune","year":"2021","unstructured":"Delaune, D., Hul, V., Karlsson, E.A., Hassanin, A., Ou, T.P., Baidaliuk, A., G\u00e1mbaro, F., Prot, M., Tu, V.T., Chea, S., et al. (2021). A novel SARS-CoV-2 related coronavirus in bats from Cambodia. Nat Commun 12, 6563.","journal-title":"Nat Commun"},{"key":"2410_CR7","first-page":"100206","volume":"3","author":"P Du","year":"2022","unstructured":"Du, P., Gao, G.F., and Wang, Q. (2022). The mysterious origins of the Omicron variant of SARS-CoV-2. Innovation 3, 100206.","journal-title":"Innovation"},{"key":"2410_CR8","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/S0149-2918(04)90032-X","volume":"26","author":"HB Fung","year":"2004","unstructured":"Fung, H.B., and Guo, Y. (2004). Enfuvirtide: a fusion inhibitor for the treatment of HIV infection. Clin Ther 26, 352\u2013378.","journal-title":"Clin Ther"},{"key":"2410_CR9","doi-asserted-by":"publisher","first-page":"13134","DOI":"10.1128\/JVI.02433-13","volume":"87","author":"J Gao","year":"2013","unstructured":"Gao, J., Lu, G., Qi, J., Li, Y., Wu, Y., Deng, Y., Geng, H., Li, H., Wang, Q., Xiao, H., et al. (2013). Structure of the fusion core and inhibition of fusion by a heptad repeat peptide derived from the S protein of Middle East respiratory syndrome coronavirus. J Virol 87, 13134\u201313140.","journal-title":"J Virol"},{"key":"2410_CR10","doi-asserted-by":"publisher","first-page":"100991","DOI":"10.1016\/j.xcrm.2023.100991","volume":"4","author":"Q He","year":"2023","unstructured":"He, Q., Wu, L., Xu, Z., Wang, X., Xie, Y., Chai, Y., Zheng, A., Zhou, J., Qiao, S., Huang, M., et al. (2023). An updated atlas of antibody evasion by SARS-CoV-2 Omicron sub-variants including BQ.1.1 and XBB. Cell Rep Med 4, 100991.","journal-title":"Cell Rep Med"},{"key":"2410_CR11","doi-asserted-by":"publisher","first-page":"105571","DOI":"10.1016\/j.antiviral.2023.105571","volume":"212","author":"Y Hu","year":"2023","unstructured":"Hu, Y., Zhu, Y., Yu, Y., Liu, N., Ju, X., Ding, Q., and He, Y. (2023). Design and characterization of novel SARS-CoV-2 fusion inhibitors with N-terminally extended HR2 peptides. Antiviral Res 212, 105571.","journal-title":"Antiviral Res"},{"key":"2410_CR12","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1016\/j.immuni.2022.06.005","volume":"55","author":"M Huang","year":"2022","unstructured":"Huang, M., Wu, L., Zheng, A., Xie, Y., He, Q., Rong, X., Han, P., Du, P., Han, P., Zhang, Z., et al. (2022). Atlas of currently available human neutralizing antibodies against SARS-CoV-2 and escape by Omicron sub-variants BA.1\/BA.1.1\/BA.2\/BA.3. Immunity 55, 1501\u20131514.e3.","journal-title":"Immunity"},{"key":"2410_CR13","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1056\/NEJMc2214302","volume":"388","author":"M Imai","year":"2023","unstructured":"Imai, M., Ito, M., Kiso, M., Yamayoshi, S., Uraki, R., Fukushi, S., Watanabe, S., Suzuki, T., Maeda, K., Sakai-Tagawa, Y., et al. (2023). Efficacy of antiviral agents against Omicron subvariants BQ.1.1 and XBB. N Engl J Med 388, 89\u201391.","journal-title":"N Engl J Med"},{"key":"2410_CR14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41580-021-00418-x","volume":"23","author":"CB Jackson","year":"2022","unstructured":"Jackson, C.B., Farzan, M., Chen, B., and Choe, H. (2022). Mechanisms of SARS-CoV-2 entry into cells. Nat Rev Mol Cell Biol 23, 3\u201320.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2410_CR15","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/365113a0","volume":"365","author":"S Jiang","year":"1993","unstructured":"Jiang, S., Lin, K., Strick, N., and Neurath, A.R. (1993). HIV-1 inhibition by a peptide. Nature 365, 113.","journal-title":"Nature"},{"key":"2410_CR16","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41421-022-00431-0","volume":"8","author":"L Li","year":"2022","unstructured":"Li, L., Han, P., Huang, B., Xie, Y., Li, W., Zhang, D., Han, P., Xu, Z., Bai, B., Zhou, J., et al. (2022). Broader-species receptor binding and structural bases of Omicron SARS-CoV-2 to both mouse and palm-civet ACE2s. Cell Discov 8, 65.","journal-title":"Cell Discov"},{"key":"2410_CR17","doi-asserted-by":"publisher","first-page":"3438","DOI":"10.1016\/j.cell.2021.05.031","volume":"184","author":"K Liu","year":"2021","unstructured":"Liu, K., Pan, X., Li, L., Yu, F., Zheng, A., Du, P., Han, P., Meng, Y., Zhang, Y., Wu, L., et al. (2021). Binding and molecular basis of the bat coronavirus RaTG13 virus to ACE2 in humans and other species. Cell 184, 3438\u20133451.e10.","journal-title":"Cell"},{"key":"2410_CR18","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/S0140-6736(04)15788-7","volume":"363","author":"S Liu","year":"2004","unstructured":"Liu, S., Xiao, G., Chen, Y., He, Y., Niu, J., Escalante, C.R., Xiong, H., Farmar, J., Debnath, A.K., Tien, P., et al. (2004). Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors. Lancet 363, 938\u2013947.","journal-title":"Lancet"},{"key":"2410_CR19","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1038\/ncomms4067","volume":"5","author":"L Lu","year":"2014","unstructured":"Lu, L., Liu, Q., Zhu, Y., Chan, K.H., Qin, L., Li, Y., Wang, Q., Chan, J.F.W., Du, L., Yu, F., et al. (2014). Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor. Nat Commun 5, 3067.","journal-title":"Nat Commun"},{"key":"2410_CR20","doi-asserted-by":"publisher","first-page":"e00961","DOI":"10.1128\/jvi.00961-22","volume":"96","author":"M Martins","year":"2022","unstructured":"Martins, M., do Nascimento, G.M., Nooruzzaman, M., Yuan, F., Chen, C., Caserta, L.C., Miller, A.D., Whittaker, G.R., Fang, Y., and Diel, D.G. (2022). The Omicron variant BA.1.1 presents a lower pathogenicity than B.1 D614G and Delta variants in a feline model of SARS-CoV-2 infection. J Virol 96, e00961\u201322.","journal-title":"J Virol"},{"key":"2410_CR21","doi-asserted-by":"publisher","first-page":"15854","DOI":"10.1074\/jbc.M110.207084","volume":"286","author":"EH Miller","year":"2011","unstructured":"Miller, E.H., Harrison, J.S., Radoshitzky, S.R., Higgins, C.D., Chi, X., Dong, L., Kuhn, J.H., Bavari, S., Lai, J.R., and Chandran, K. (2011). Inhibition of Ebola virus entry by a C-peptide targeted to endosomes. J Biol Chem 286, 15854\u201315861.","journal-title":"J Biol Chem"},{"key":"2410_CR22","doi-asserted-by":"publisher","first-page":"e107786","DOI":"10.15252\/embj.2021107786","volume":"40","author":"S Niu","year":"2021","unstructured":"Niu, S., Wang, J., Bai, B., Wu, L., Zheng, A., Chen, Q., Du, P., Han, P., Zhang, Y., Jia, Y., et al. (2021). Molecular basis of cross-species ACE2 interactions with SARS-CoV-2-like viruses ofpangolin origin. EMBO J 40, e107786.","journal-title":"EMBO J"},{"key":"2410_CR23","doi-asserted-by":"publisher","first-page":"12648","DOI":"10.1021\/jacs.9b04615","volume":"141","author":"VK Outlaw","year":"2019","unstructured":"Outlaw, V.K., Bottom-Tanzer, S., Kreitler, D.F., Gellman, S.H., Porotto, M., and Moscona, A. (2019). Dual inhibition of human parainfluenza type 3 and respiratory syncytial virus infectivity with a single agent. J Am Chem Soc 141, 12648\u201312656.","journal-title":"J Am Chem Soc"},{"key":"2410_CR24","doi-asserted-by":"publisher","first-page":"e01935","DOI":"10.1128\/mBio.01935-20","volume":"11","author":"VK Outlaw","year":"2020","unstructured":"Outlaw, V.K., Bovier, F.T., Mears, M.C., Cajimat, M.N., Zhu, Y., Lin, M.J., Addetia, A., Lieberman, N.A.P., Peddu, V., Xie, X., et al. (2020). In-hibition of coronavirus entry in vitro and ex vivo by a lipid-conjugated peptide derived from the SARS-CoV-2 spike glycoprotein HRC domain. mBio 11, e01935\u201301920.","journal-title":"mBio"},{"key":"2410_CR25","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41586-021-04389-z","volume":"602","author":"D Planas","year":"2022","unstructured":"Planas, D., Saunders, N., Maes, P., Guivel-Benhassine, F., Planchais, C., Buchrieser, J., Bolland, W.H., Porrot, F., Staropoli, I., Lemoine, F., et al. (2022). Considerable escape of SARS-CoV-2 Omicron to antibody neutralization. Nature 602, 671\u2013675.","journal-title":"Nature"},{"key":"2410_CR26","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1007\/s11427-021-2164-6","volume":"66","author":"H Que","year":"2023","unstructured":"Que, H., Chen, L., and Wei, X. (2023). SARS-CoV-2 variants, immune escape, COVID-19 vaccine, and therapeutic strategies. Sci China Life Sci 66, 406\u2013410.","journal-title":"Sci China Life Sci"},{"key":"2410_CR27","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41586-020-2381-y","volume":"584","author":"R Shi","year":"2020","unstructured":"Shi, R., Shan, C., Duan, X., Chen, Z., Liu, P., Song, J., Song, T., Bi, X., Han, C., Wu, L., et al. (2020). A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2. Nature 584, 120\u2013124.","journal-title":"Nature"},{"key":"2410_CR28","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1080\/22221751.2020.1770631","volume":"9","author":"H Sun","year":"2020","unstructured":"Sun, H., Li, Y., Liu, P., Qiao, C., Wang, X., Wu, L., Liu, K., Hu, Y., Su, C., Tan, S., et al. (2020). Structural basis of HCoV-19 fusion core and an effective inhibition peptide against virus entry. Emerg Microbes Infect 9, 1238\u20131241.","journal-title":"Emerg Microbes Infect"},{"key":"2410_CR29","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/s41586-022-04532-4","volume":"604","author":"S Temmam","year":"2022","unstructured":"Temmam, S., Vongphayloth, K., Baquero, E., Munier, S., Bonomi, M., Regnault, B., Douangboubpha, B., Karami, Y., Chr\u00e9tien, D., Sanamxay, D., et al. (2022). Bat coronaviruses related to SARS-CoV-2 and infectious for human cells. Nature 604, 330\u2013336.","journal-title":"Nature"},{"key":"2410_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/9780470179727","volume-title":"Combating the Threat of Pandemic Influenza: Drug Discovery Approaches","author":"PF Torrence","year":"2007","unstructured":"Torrence, P.F. (2007). Combating the Threat of Pandemic Influenza: Drug Discovery Approaches. Hoboken: John Wiley & Sons."},{"key":"2410_CR31","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1016\/j.cell.2022.06.005","volume":"185","author":"A Tuekprakhon","year":"2022","unstructured":"Tuekprakhon, A., Nutalai, R., Dijokaite-Guraliuc, A., Zhou, D., Ginn, H. M., Selvaraj, M., Liu, C., Mentzer, A.J., Supasa, P., Duyvesteyn, H.M. E., et al. (2022). Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum. Cell 185, 2422\u20132433.e13.","journal-title":"Cell"},{"key":"2410_CR32","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.cell.2020.03.045","volume":"181","author":"Q Wang","year":"2020","unstructured":"Wang, Q., Zhang, Y., Wu, L., Niu, S., Song, C., Zhang, Z., Lu, G., Qiao, C., Hu, Y., Yuen, K.Y., et al. (2020). Structural and functional basis of SARS-CoV-2 entry by using human ACE2. Cell 181, 894\u2013904.e9.","journal-title":"Cell"},{"key":"2410_CR33","doi-asserted-by":"publisher","first-page":"10194","DOI":"10.1128\/JVI.74.21.10194-10201.2000","volume":"74","author":"S Watanabe","year":"2000","unstructured":"Watanabe, S., Takada, A., Watanabe, T., Ito, H., Kida, H., and Kawaoka, Y. (2000). Functional importance of the coiled-coil of the Ebola virus glycoprotein. J Virol 74, 10194\u201310201.","journal-title":"J Virol"},{"key":"2410_CR34","unstructured":"WHO. (2022). Weekly epidemiological update on COVID-19. 22 March 2022."},{"key":"2410_CR35","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/s41422-020-0305-x","volume":"30","author":"S Xia","year":"2020","unstructured":"Xia, S., Liu, M., Wang, C., Xu, W., Lan, Q., Feng, S., Qi, F., Bao, L., Du, L., Liu, S., et al. (2020). Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion. Cell Res 30, 343\u2013355.","journal-title":"Cell Res"},{"key":"2410_CR36","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.bsheal.2022.01.002","volume":"4","author":"Z Xu","year":"2022","unstructured":"Xu, Z., Liu, K., and Gao, G.F. (2022). Omicron variant of SARS-CoV-2 imposes a new challenge for the global public health. Biosaf Health 4, 147\u2013149.","journal-title":"Biosaf Health"},{"key":"2410_CR37","doi-asserted-by":"publisher","first-page":"e2210990119","DOI":"10.1073\/pnas.2210990119","volume":"119","author":"K Yang","year":"2022","unstructured":"Yang, K., Wang, C., Kreutzberger, A.J.B., Ojha, R., Kuivanen, S., Couoh-Cardel, S., Muratcioglu, S., Eisen, T.J., White, K.I., Held, R.G., et al. (2022a). Nanomolar inhibition of SARS-CoV-2 infection by an unmodified peptide targeting the prehairpin intermediate of the spike protein. Proc Natl Acad Sci USA 119, e2210990119.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2410_CR38","doi-asserted-by":"publisher","first-page":"e2119467119","DOI":"10.1073\/pnas.2119467119","volume":"119","author":"K Yang","year":"2022","unstructured":"Yang, K., Wang, C., White, K.I., Pfuetzner, R.A., Esquivies, L., and Brunger, A.T. (2022b). Structural conservation among variants of the SARS-CoV-2 spike postfusion bundle. Proc Natl Acad Sci USA 119, e2119467119.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2410_CR39","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1006\/viro.1996.0459","volume":"223","author":"Q Yao","year":"1996","unstructured":"Yao, Q., and Compans, R.W. (1996). Peptides corresponding to the heptad repeat sequence of human parainfluenza virus fusion protein are potent inhibitors of virus infection. Virology 223, 103\u2013112.","journal-title":"Virology"},{"key":"2410_CR40","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1080\/22221751.2021.1937329","volume":"10","author":"D Yu","year":"2021","unstructured":"Yu, D., Zhu, Y., Jiao, T., Wu, T., Xiao, X., Qin, B., Chong, H., Lei, X., Ren, L., Cui, S., et al. (2021). Structure-based design and characterization of novel fusion-inhibitory lipopeptides against SARS-CoV-2 and emerging variants. Emerg Microbes Infect 10, 1227\u20131240.","journal-title":"Emerg Microbes Infect"},{"key":"2410_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/22221751.2021.2017757","volume":"11","author":"L Zhang","year":"2022","unstructured":"Zhang, L., Li, Q., Liang, Z., Li, T., Liu, S., Cui, Q., Nie, J., Wu, Q., Qu, X., Huang, W., et al. (2022). The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron. Emerg Microbes Infect 11, 1\u20135.","journal-title":"Emerg Microbes Infect"},{"key":"2410_CR42","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41392-021-00821-y","volume":"7","author":"A Zheng","year":"2022","unstructured":"Zheng, A., Wu, L., Ma, R., Han, P., Huang, B., Qiao, C., Wang, Q., Tan, W., Gao, G.F., and Han, P. (2022). A binding-enhanced but enzymatic activity-eliminated human ACE2 efficiently neutralizes SARS-CoV-2 variants. Sig Transduct Target Ther 7, 10.","journal-title":"Sig Transduct Target Ther"},{"key":"2410_CR43","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12985-022-01827-w","volume":"19","author":"B Zhou","year":"2022","unstructured":"Zhou, B., Cheng, L., Song, S., Guo, H., Shen, S., Wang, H., Ge, X., Liu, L., Ju, B., and Zhang, Z. (2022). Identification and application of a pair of noncompeting monoclonal antibodies broadly binding to the nucleocapsid proteins of SARS-CoV-2 variants including Omicron. Virol J 19, 96.","journal-title":"Virol J"},{"key":"2410_CR44","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.bbrc.2004.04.141","volume":"319","author":"J Zhu","year":"2004","unstructured":"Zhu, J., Xiao, G., Xu, Y., Yuan, F., Zheng, C., Liu, Y., Yan, H., Cole, D.K., Bell, J.I., Rao, Z., et al. (2004). Following the rule: formation of the 6-helix bundle of the fusion core from severe acute respiratory syndrome coronavirus spike protein and identification of potent peptide inhibitors. Biochem Biophys Res Commun 319, 283\u2013288.","journal-title":"Biochem Biophys Res Commun"},{"key":"2410_CR45","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1080\/22221751.2022.2098060","volume":"11","author":"Y Zhu","year":"2022","unstructured":"Zhu, Y., Dong, X., Liu, N., Wu, T., Chong, H., Lei, X., Ren, L., Wang, J., and He, Y. (2022a). SARS-CoV-2 fusion-inhibitory lipopeptides maintain high potency against divergent variants of concern including Omicron. Emerg Microbes Infect 11, 1819\u20131827.","journal-title":"Emerg Microbes Infect"},{"key":"2410_CR46","doi-asserted-by":"publisher","first-page":"105445","DOI":"10.1016\/j.antiviral.2022.105445","volume":"208","author":"Y Zhu","year":"2022","unstructured":"Zhu, Y., Hu, Y., Liu, N., Chong, H., and He, Y. (2022b). Potent inhibition of diverse Omicron sublineages by SARS-CoV-2 fusion-inhibitory lipopeptides. Antiviral Res 208, 105445.","journal-title":"Antiviral Res"},{"key":"2410_CR47","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/s41392-021-00698-x","volume":"6","author":"Y Zhu","year":"2021","unstructured":"Zhu, Y., Yu, D., Hu, Y., Wu, T., Chong, H., and He, Y. (2021). SARS-CoV-2-derived fusion inhibitor lipopeptides exhibit highly potent and broad-spectrum activity against divergent human coronaviruses. Sig Transduct Target Ther 6, 294.","journal-title":"Sig Transduct Target Ther"},{"key":"2410_CR48","doi-asserted-by":"publisher","first-page":"e00635","DOI":"10.1128\/JVI.00635-20","volume":"94","author":"Y Zhu","year":"2020","unstructured":"Zhu, Y., Yu, D., Yan, H., Chong, H., and He, Y. (2020). Design of potent membrane fusion inhibitors against SARS-CoV-2, an emerging coronavirus with high fusogenic activity. J Virol 94, e00635\u201320.","journal-title":"J Virol"}],"container-title":["Science China Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-023-2410-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11427-023-2410-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-023-2410-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T05:07:02Z","timestamp":1698210422000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11427-023-2410-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,11]]},"references-count":48,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["2410"],"URL":"https:\/\/doi.org\/10.1007\/s11427-023-2410-5","relation":{},"ISSN":["1674-7305","1869-1889"],"issn-type":[{"value":"1674-7305","type":"print"},{"value":"1869-1889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,11]]},"assertion":[{"value":"10 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"<b>Compliance and ethics<\/b> G.F.G., Q.W., S.Z., L.W., A.Z., Y.T., Y.C., and J.C. are listed as the coinventors of the patents for the peptide fusion inhibitors described in this study. S.Z. is a founder of Hybio Pharmaceutical Co., Ltd., and Y. T. and J.C. are employees of this company. Other authors declare no conflict of interest. All animal experiments in this study were approved by the Institutional Animal Care and Use Committee (No.: WIVA17202005) in Wuhan Institute of Virology, CAS. All authors state that they conformed with the Helsinki Declaration of 1975 concerning Human and Animal Rights.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}